Guy A. Cabral - Publications

Affiliations: 
Virginia Commonwealth University, Richmond, VA, United States 
Area:
Microbiology Biology

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Abood M, Alexander SP, Barth F, Bonner TI, Bradshaw H, Cabral G, Casellas P, Cravatt BF, Devane WA, Di Marzo V, Elphick MR, Felder CC, Greasley P, Herkenham M, Howlett AC, et al. Cannabinoid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database Iuphar/Bps Guide to Pharmacology Cite. 2019. DOI: 10.2218/gtopdb/f13/2019.4  0.307
2017 Jamerson M, Schmoyer JA, Park J, Marciano-Cabral F, Cabral G. Identification of Naegleria fowleri Proteins Linked to Primary Amebic Meningoencephalitis. Microbiology (Reading, England). PMID 28086072 DOI: 10.1099/Mic.0.000428  0.311
2016 Alsharari SD, Bagdas D, Akbarali HI, Lichtman PA, Raborn ES, Cabral GA, Carroll FI, McGee EA, Damaj MI. Sex differences and drug dose influence the role of the α7 nicotinic acetylcholine receptor in the Mouse Dextran Sodium Sulfate-Induced Colitis Model. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 27639096 DOI: 10.1093/Ntr/Ntw245  0.759
2015 Cabral GA, Ferreira GA, Jamerson MJ. Endocannabinoids and the Immune System in Health and Disease. Handbook of Experimental Pharmacology. 231: 185-211. PMID 26408161 DOI: 10.1007/978-3-319-20825-1_6  0.46
2015 Cabral GA, Rogers TJ, Lichtman AH. Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 10: 193-203. PMID 26054900 DOI: 10.1007/S11481-015-9615-Z  0.465
2015 Maccarrone M, Bab I, Bíró T, Cabral GA, Dey SK, Di Marzo V, Konje JC, Kunos G, Mechoulam R, Pacher P, Sharkey KA, Zimmer A. Endocannabinoid signaling at the periphery: 50 years after THC. Trends in Pharmacological Sciences. 36: 277-96. PMID 25796370 DOI: 10.1016/J.Tips.2015.02.008  0.305
2015 Vyas IK, Jamerson M, Cabral GA, Marciano-Cabral F. Identification of peptidases in highly pathogenic vs. weakly pathogenic Naegleria fowleri amebae. The Journal of Eukaryotic Microbiology. 62: 51-9. PMID 25066578 DOI: 10.1111/Jeu.12152  0.305
2015 AlSharari S, Bagdas D, Akbarali H, Cabral GA, Carroll IF, Damaj I, Lichtman P. Sex Differences and Drug Dose Influence the Role of the α-7 Nicotinic Acetylcholine Receptor in the Mouse Dextran Sodium Sulfate-Induced Colitis Model: 1826 The American Journal of Gastroenterology. 110. DOI: 10.14309/00000434-201510001-01826  0.383
2014 Cabral GA, Jamerson M, Rogers TJ. Editorial: Does immune dysfunction persist into adulthood after adolescent use of marijuana? Journal of Leukocyte Biology. 96: 507-9. PMID 25271293 DOI: 10.1189/Jlb.3Ce0414-186Rr  0.391
2014 Cabral GA, Jamerson M. Marijuana use and brain immune mechanisms. International Review of Neurobiology. 118: 199-230. PMID 25175866 DOI: 10.1016/B978-0-12-801284-0.00008-7  0.368
2014 Raborn ES, Jamerson M, Marciano-Cabral F, Cabral GA. Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins. Life Sciences. 104: 15-23. PMID 24742657 DOI: 10.1016/J.Lfs.2014.04.008  0.752
2013 McGee E, AlShari S, Akbaralib H, Raborn E, Cabral G, Damaj M. Sex differences influencing the role of α-7 nicotinic acetylcholine receptor in murine dextran sodium sulfate-induced colitis model Fertility and Sterility. 100: S333-S334. DOI: 10.1016/J.Fertnstert.2013.07.917  0.758
2011 Fraga D, Raborn ES, Ferreira GA, Cabral GA. Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 6: 566-77. PMID 21735070 DOI: 10.1007/S11481-011-9291-6  0.804
2010 Harrison JL, Ferreira GA, Raborn ES, Lafrenaye AD, Marciano-Cabral F, Cabral GA. Acanthamoeba culbertsoni elicits soluble factors that exert anti-microglial cell activity. Infection and Immunity. 78: 4001-11. PMID 20605979 DOI: 10.1128/Iai.00047-10  0.75
2010 Raborn ES, Cabral GA. Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor. The Journal of Pharmacology and Experimental Therapeutics. 333: 319-27. PMID 20089805 DOI: 10.1124/Jpet.109.163055  0.799
2010 Rocha-Azevedo Bd, Jamerson M, Cabral GA, Marciano-Cabral F. Acanthamoeba culbertsoni: analysis of amoebic adhesion and invasion on extracellular matrix components collagen I and laminin-1. Experimental Parasitology. 126: 79-84. PMID 19698710 DOI: 10.1016/J.Exppara.2009.08.004  0.322
2009 Rocha-Azevedo BD, Jamerson M, Cabral GA, Silva-Filho FC, Marciano-Cabral F. Acanthamoeba interaction with extracellular matrix glycoproteins: biological and biochemical characterization and role in cytotoxicity and invasiveness. The Journal of Eukaryotic Microbiology. 56: 270-8. PMID 19527355 DOI: 10.1111/J.1550-7408.2009.00399.X  0.331
2009 Cabral GA, Griffin-Thomas L. Emerging role of the cannabinoid receptor CB2 in immune regulation: therapeutic prospects for neuroinflammation. Expert Reviews in Molecular Medicine. 11: e3. PMID 19152719 DOI: 10.1017/S1462399409000957  0.748
2008 Cabral GA, Griffin-Thomas L. Cannabinoids as therapeutic agents for ablating neuroinflammatory disease. Endocrine, Metabolic & Immune Disorders Drug Targets. 8: 159-72. PMID 18782012 DOI: 10.2174/187153008785700118  0.366
2008 Raborn ES, Marciano-Cabral F, Buckley NE, Martin BR, Cabral GA. The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 3: 117-29. PMID 18247131 DOI: 10.1007/S11481-007-9077-Z  0.79
2008 Cabral GA, Raborn ES, Griffin L, Dennis J, Marciano-Cabral F. CB2 receptors in the brain: role in central immune function. British Journal of Pharmacology. 153: 240-51. PMID 18037916 DOI: 10.1038/Sj.Bjp.0707584  0.794
2007 Rock RB, Gekker G, Hu S, Sheng WS, Cabral GA, Martin BR, Peterson PK. WIN55,212-2-mediated inhibition of HIV-1 expression in microglial cells: involvement of cannabinoid receptors. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 2: 178-83. PMID 18040842 DOI: 10.1007/S11481-006-9040-4  0.506
2007 Marciano-Cabral F, Cabral GA. The immune response to Naegleria fowleri amebae and pathogenesis of infection. Fems Immunology and Medical Microbiology. 51: 243-59. PMID 17894804 DOI: 10.1111/J.1574-695X.2007.00332.X  0.312
2006 Cabral GA. Drugs of abuse, immune modulation, and AIDS. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 1: 280-95. PMID 18040805 DOI: 10.1007/S11481-006-9023-5  0.422
2006 Klein TW, Cabral GA. Cannabinoid-induced immune suppression and modulation of antigen-presenting cells. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 1: 50-64. PMID 18040791 DOI: 10.1007/S11481-005-9007-X  0.403
2006 Marciano-Cabral F, Raborn ES, Martin BR, Cabral GA. Delta-9-tetrahydrocannabinol, the major psychoactive component in marijuana, inhibits macrophage chemotaxis to Acanthamoeba. The Journal of Eukaryotic Microbiology. 53: S15-7. PMID 17169039 DOI: 10.1111/J.1550-7408.2006.00158.X  0.751
2006 Cabral GA, Staab A. Effects on the immune system. Handbook of Experimental Pharmacology. 385-423. PMID 16596782 DOI: 10.1007/3-540-26573-2_13  0.409
2006 Cabral GA. Localization of cannabinoid receptors using immunoperoxidase methods. Methods in Molecular Medicine. 123: 41-69. PMID 16506401 DOI: 10.1385/1-59259-999-0:41  0.404
2005 Cabral GA, Marciano-Cabral F. Cannabinoid receptors in microglia of the central nervous system: Immune functional relevance Journal of Leukocyte Biology. 78: 1192-1197. PMID 16204639 DOI: 10.1189/jlb.0405216  0.43
2005 Cabral GA. Lipids as bioeffectors in the immune system. Life Sciences. 77: 1699-710. PMID 15950989 DOI: 10.1016/J.Lfs.2005.05.013  0.381
2005 Sheng WS, Hu S, Min X, Cabral GA, Lokensgard JR, Peterson PK. Synthetic cannabinoid WIN55,212-2 inhibits generation of inflammatory mediators by IL-1beta-stimulated human astrocytes. Glia. 49: 211-9. PMID 15390091 DOI: 10.1002/Glia.20108  0.358
2004 Marciano-Cabral F, Ludwick C, Puffenbarger RA, Cabral GA. Differential stimulation of microglial pro-inflammatory cytokines by Acanthamoeba culbertsoni versus Acanthamoeba castellanii. The Journal of Eukaryotic Microbiology. 51: 472-9. PMID 15352331 DOI: 10.1111/J.1550-7408.2004.Tb00398.X  0.373
2004 Cabral GA, Marciano-Cabral F. Cannabinoid-mediated exacerbation of brain infection by opportunistic amebae. Journal of Neuroimmunology. 147: 127-30. PMID 14741443 DOI: 10.1016/J.Jneuroim.2003.10.027  0.361
2004 Peterson PK, Gekker G, Hu S, Cabral G, Lokensgard JR. Cannabinoids and morphine differentially affect HIV-1 expression in CD4(+) lymphocyte and microglial cell cultures. Journal of Neuroimmunology. 147: 123-6. PMID 14741442 DOI: 10.1016/J.Jneuroim.2003.10.026  0.339
2003 Marciano-Cabral F, Han K, Powell E, Ferguson T, Cabral G. Interaction of an Acanthamoeba human isolate harboring bacteria with murine peritoneal macrophages. The Journal of Eukaryotic Microbiology. 50: 516-9. PMID 14736148 DOI: 10.1111/J.1550-7408.2003.Tb00615.X  0.317
2003 Olson JM, Kennedy SJ, Cabral GA. Expression of the murine CB2 cannabinoid receptor using a recombinant Semliki Forest virus. Biochemical Pharmacology. 65: 1931-42. PMID 12787873 DOI: 10.1016/S0006-2952(03)00200-4  0.39
2002 McAllister SD, Tao Q, Barnett-Norris J, Buehner K, Hurst DP, Guarnieri F, Reggio PH, Nowell Harmon KW, Cabral GA, Abood ME. A critical role for a tyrosine residue in the cannabinoid receptors for ligand recognition. Biochemical Pharmacology. 63: 2121-36. PMID 12110371 DOI: 10.1016/S0006-2952(02)01031-6  0.383
2002 Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological Reviews. 54: 161-202. PMID 12037135 DOI: 10.1124/Pr.54.2.161  0.461
2002 Carlisle SJ, Marciano-Cabral F, Staab A, Ludwick C, Cabral GA. Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation International Immunopharmacology. 2: 69-82. PMID 11789671 DOI: 10.1016/S1567-5769(01)00147-3  0.468
2002 Cabral GA, Harmon KN, Carlisle SJ. Cannabinoid-mediated inhibition of inducible nitric oxide production by rat microglial cells: evidence for CB1 receptor participation. Advances in Experimental Medicine and Biology. 493: 207-14. PMID 11727767 DOI: 10.1007/0-306-47611-8_24  0.489
2001 Marciano-Cabral F, Ferguson T, Bradley SG, Cabral G. Delta-9-tetrahydrocannabinol (THC), the major psychoactive component of marijuana, exacerbates brain infection by Acanthamoeba. The Journal of Eukaryotic Microbiology. 4S-5S. PMID 11906077 DOI: 10.1111/J.1550-7408.2001.Tb00433.X  0.343
2000 Marciano-Cabral F, Puffenbarger R, Cabral GA. The increasing importance of Acanthamoeba infections Journal of Eukaryotic Microbiology. 47: 29-36. PMID 10651293 DOI: 10.1111/J.1550-7408.2000.Tb00007.X  0.403
2000 Puffenbarger RA, Boothe AC, Cabral GA. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells. Glia. 29: 58-69. PMID 10594923 DOI: 10.1002/(Sici)1098-1136(20000101)29:1<58::Aid-Glia6>3.0.Co;2-W  0.341
1998 Nowell KW, Dove Pettit DA, Cabral WA, Zimmerman HW, Abood ME, Cabral GA. High-level expression of the human CB2 cannabinoid receptor using a baculovirus system Biochemical Pharmacology. 55: 1893-1905. PMID 9714308 DOI: 10.1016/S0006-2952(98)00081-1  0.43
1998 Cabral GA, Dove Pettit DA. Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease. Journal of Neuroimmunology. 83: 116-23. PMID 9610679 DOI: 10.1016/S0165-5728(97)00227-0  0.354
1998 Pettit DA, Harrison MP, Olson JM, Spencer RF, Cabral GA. Immunohistochemical localization of the neural cannabinoid receptor in rat brain. Journal of Neuroscience Research. 51: 391-402. PMID 9486774 DOI: 10.1002/(Sici)1097-4547(19980201)51:3<391::Aid-Jnr12>3.0.Co;2-A  0.405
1996 Pettit DA, Anders DL, Harrison MP, Cabral GA. Cannabinoid receptor expression in immune cells. Advances in Experimental Medicine and Biology. 402: 119-29. PMID 8787652 DOI: 10.1007/978-1-4613-0407-4_17  0.449
1995 Cabral GA, Toney DM, Fischer-Stenger K, Harrison MP, Marciano-Cabral F. Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells. Life Sciences. 56: 2065-72. PMID 7776833 DOI: 10.1016/0024-3205(95)00190-H  0.389
1995 Burnette-Curley D, Cabral GA. Differential inhibition of RAW264.7 macrophage tumoricidal activity by delta 9tetrahydrocannabinol. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 210: 64-76. PMID 7675800 DOI: 10.3181/00379727-210-43926  0.436
1994 Cabral GA, Fischer-Stenger K. Inhibition of macrophage inducible protein expression by delta-9-tetrahydrocannabinol. Life Sciences. 54: 1831-44. PMID 8196497 DOI: 10.1016/0024-3205(94)90122-8  0.393
1994 Pettit DAD, Showalter VM, Abood ME, Cabral GA. Expression of a cannabinoid receptor in baculo virus-infected insect cells Biochemical Pharmacology. 48: 1231-1243. PMID 7945417 DOI: 10.1016/0006-2952(94)90161-9  0.421
1993 Burnette-Curley D, Marciano-Cabral F, Fischer-Stenger K, Cabral GA. Delta-9-tetrahydrocannabinol inhibits cell contact-dependent cytotoxicity of bacillus calmétte-guérin-activated macrophages International Journal of Immunopharmacology. 15: 371-382. PMID 8389327 DOI: 10.1016/0192-0561(93)90048-4  0.414
1993 Cabral GA, Pettit DA, Fischer-Stenger K. Marijuana and host resistance to herpesvirus infection. Advances in Experimental Medicine and Biology. 335: 95-106. PMID 7694448 DOI: 10.1007/978-1-4615-2980-4_14  0.401
1992 Fischer-Stenger K, Updegrove AW, Cabral GA. Delta 9-tetrahydrocannabinol decreases cytotoxic T lymphocyte activity to herpes simplex virus type 1-infected cells. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 200: 422-30. PMID 1319584 DOI: 10.3181/00379727-200-43452  0.342
1992 Cabral GA, Vasquez R. Δ9-Tetrahydrocannabinol Suppresses Macrophage Extrinsic Antiherpesvirus Activity Proceedings of the Society For Experimental Biology and Medicine. 199: 255-263. PMID 1311105 DOI: 10.3181/00379727-199-43356  0.407
1991 Cabral GA, Vasquez R. Effects of marijuana on macrophage function Advances in Experimental Medicine and Biology. 288: 93-106. PMID 1659141 DOI: 10.1007/978-1-4684-5925-8_10  0.454
1991 Cabral G, Fischer-Stenger K, Burnette D, Marciano-Cabral F. Delta-9-tetrahydrocannabinol suppresses cell contact-dependent cytolytic activity International Journal of Immunopharmacology. 13: 785. DOI: 10.1016/0192-0561(91)90331-Z  0.322
1990 Fischer-Stenger K, Cabral GA, Marciano-Cabral F. The interaction of Naegleria fowleri amoebae with murine macrophage cell lines Journal of Protozoology. 37: 168-173. PMID 2359044 DOI: 10.1111/J.1550-7408.1990.Tb01122.X  0.388
1989 Cabral GA, Mishkin EM. Delta-9-tetrahydrocannabinol inhibits macrophage protein expression in response to bacterial immunomodulators. Journal of Toxicology and Environmental Health. 26: 175-82. PMID 2537903 DOI: 10.1080/15287398909531243  0.374
1988 Cabral GA, McNerney PJ, Mishkin EM. Delta-9-tetrahydrocannabinol inhibits the splenocyte proliferative response to herpes simplex virus type 2. Immunopharmacology and Immunotoxicology. 9: 361-70. PMID 2830329 DOI: 10.3109/08923978709035219  0.372
1987 Cabral GA, McNerney PJ, Mishkin EM. Effect of micromolar concentrations of delta-9-tetrahydrocannabinol on herpes simplex virus type 2 replication in vitro. Journal of Toxicology and Environmental Health. 21: 277-93. PMID 3035199 DOI: 10.1080/15287398709531019  0.327
1987 Mishkin EM, Cabral GA. Inhibition of cell-associated herpes simplex virus type 2 glycoproteins by delta 9-tetrahydrocannabinol. Proceedings of the Society For Experimental Biology and Medicine. Society For Experimental Biology and Medicine (New York, N.Y.). 185: 41-8. PMID 3033681 DOI: 10.3181/00379727-185-42514  0.352
1987 Cabral GA, McNerney PJ, Mishkin EM. Interaction of delta-9-tetrahydrocannabinol with rat B103 neuroblastoma cells. Archives of Toxicology. 60: 438-49. PMID 2821958 DOI: 10.1007/Bf00302387  0.317
1975 Cabral GA, Chairez R, Marciano-Cabral F, Suarez M, Dreesman GR, Melnick JL, Hollinger FB. Cell mediated immunity in guinea pigs to subunits derived from hepatitis B surface antigen Infection and Immunity. 12: 564-570. PMID 1165121 DOI: 10.1128/Iai.12.3.564-570.1975  0.357
Show low-probability matches.